Peptides of the endozepine family, including diazepam-binding inhibitor, the triakontatetraneuropeptide, and the octadecaneuropeptide (ODN), act through three types of receptors, that is, central-type benzodiazepine receptors (CBR), peripheral-type (mitochondrial) benzodiazepine receptors (PBR) and a metabotropic receptor positively coupled to phospholipase C via a pertussis toxin-sensitive G protein. We have previously reported that ODN exerts a potent anorexigenic effect in rat and we have found that the action of ODN is not affected by the mixed CBR/PBR agonist diazepam. In the present report, we have tested the possible involvement of the metabotropic receptor in the anorexigenic activity of ODN. Intracerebroventricular administration of the C-terminal octapeptide (OP) and its head-to-tail cyclic analog cyclo 1-8 OP (cOP) at a dose of 100 ng mimicked the inhibitory effect of ODN on food intake in fooddeprived mice. The specific CBR antagonist flumazenil and the PBR antagonist PK11195 did not prevent the effect of ODN, OP, and cOP on food consumption. In contrast, the selective metabotropic endozepine receptor antagonist cyclo 1-8 [DLeu 5 ]OP (100-1000 ng; cDLOP) suppressed the anorexigenic effect of ODN, OP, and cOP. At the highest concentration tested (1000 ng), cDLOP provoked by itself a significant increase in food intake. Taken together, the present results indicate that the anorexigenic effect of ODN and OP is mediated through activation of the metabotropic receptor recently characterized in astrocytes. The data also suggest that endogenous ODN, acting via this receptor, exerts an inhibitory tone on feeding behavior.
INTRODUCTION
The term endozepines designates a family of regulatory neuropeptides that have been originally isolated from rat brain extracts on the basis of their ability to displace benzodiazepines from their binding sites (Guidotti et al, 1983; Tonon et al, 2006) . All endozepines characterized so far derive from diazepam-binding inhibitor (DBI), an 86 amino-acid polypeptide precursor which has the potential to generate several biologically active fragments including the triakontatetraneuropeptide DBI 17-50 (TTN) and the octadecaneuropeptide DBI [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] (ODN) (Ferrero et al, 1986) . The DBI gene is widely expressed in the central nervous system (Alho et al, 1988; Tong et al, 1991; Yanase et al, 2002) . In particular, high concentrations of endozepines have been found in brain areas which play a major role in the control of feeding behavior such as the arcute nucleus, the dorso-medial and ventro-medial hypothalamic nuclei, and the lateral hypothalamic area (Alho et al, 1985; Malagon et al, 1993; Tonon et al, 1990) . Intracerebroventricular (i.c.v.) injection of low doses of ODN causes a marked reduction of food consumption in both food deprived and normally fed rodents (Garcia de Mateos-Verchere et al, 2001) . The anorexigenic effect of ODN is long lasting, does not give rise to rapid tolerance, and is associated with a substantial loss of weight (Garcia de Mateos-Verchere et al, 2001) . In rats deprived of food for 12 h, i.c.v. administration of ODN reduces the expression of neuropeptide Y (NPY), an orexigenic neuropeptide, and activates the expression of proopiomelanocortin, the precursor of the anorexigenic peptide a-melanocyte-stimulating hormone (Compère et al, 2003 (Compère et al, , 2005 , suggesting that NPY-and POMC-producing neurons of the arcute nucleus are involved in the anorexigenic effect of ODN.
The biological effects of endozepines are mediated through three types of receptors. DBI and ODN act as inverse agonists of central-type benzodiazepine receptors (CBR) associated with the GABA A receptor complex (Guidotti et al, 1983; Tonon et al, 1989; Bormann, 1991; Louiset et al, 1993) . TTN acts preferentially through peripheral-type benzodiazepine receptors (PBR) located either at the outer mitochondrial membrane or at the plasma membrane level Berkovich et al, 1990; Gandolfo et al, 2001) . Finally, ODN can also activate a metabotropic receptor positively coupled to phospholipase C through a pertussis toxin-sensitive G-protein (Patte et al, 1995; Gandolfo et al, 1997) . We have previously shown that the anorexigenic effect of ODN was not affected by the mixed CBR/PBR agonist diazepam (Garcia de MateosVerchere et al, 2001) . The aim of the present study was to investigate the possible involvement of the metabotropic receptor in the action of endozepines on feeding behavior.
MATERIALS AND METHODS

Animals
Male Swiss albinos CD1 mice (Iffa-Credo/Charles River, Saint-Germain sur l'Arbresle, France), weighing 22-25 g, were housed 20 in Makrolon cages (L: 40 cm, W: 25 cm, and H: 18 cm), with free access to standard semisynthetic laboratory diet (U.A.R., Villemoisson-sur-Orge, France) and tap water. The animals were kept in a ventilated room at a temperature of 22711C under a 12-h light/12-h dark cycle (light on between 0700 and 1900).
All the experiments were carried out between 0900 and 1800 in testing rooms adjacent to the animal rooms. Animal manipulations were performed according to the European Community Council Directive of 24 November 1986 (86:609:EEC) , were approved by the local Ethical Committee (authorization numbers: N/10-04-04-12 and N/13-04-04-15) and were conducted by authorized investigators. Each animal was used once and then immediately killed.
Drugs and Solutions
The metabotropic endozepine receptor agonists ODN (Gln-Ala-Thr-Val-Gly-Asp-Val-Asn-Thr-Asp-Arg-Pro-GlyLeu-Leu-Asp-Leu-Lys), octapeptide (OP) (Arg-Pro-GlyLeu-Leu-Asp-Leu-Lys) and cyclo 1-8 OP (Arg-Pro-Gly-LeuLeu-Asp-Leu-Lys; cOP), and the metabotropic endozepine receptor antagonist cyclo 1-8 [DLeu 5 ]OP (Arg-Pro-Gly-LeuDLeu-Asp-Leu-Lys; cDLOP) were synthesized by solid phase methodology as described previously (Leprince et al, 1998 . The peptides were dissolved in saline (0.9% NaCl). Flumazenil (Ro 15-1788) and PK11195 (Sigma Aldrich, Saint-Quentin Fallavier, France) were dissolved in 2.5% dimethylsulfoxide in saline. For PK11195, 0.5% Tween-80 was added to facilitate solubilization. All solutions were prepared just before injections.
I.c.v. Injection
Free-hand i.c.v. injections (10 ml/mouse) of saline, peptides and/or drugs were made in the left ventricle according to the procedure of Haley and McCormick (1957) , using a microsyringe (50 ml; Hamilton, Bonaduz, Switzerland) connected to a needle (diameter 0.5 mm), of which the bevel protruded only 3.5 mm from a guard limiting its penetration into the brain. The injection in immobilized mice lasted approximately 5 s. I.c.v. injections were performed by an experienced investigator, who frequently controlled the regularity and success of the injections, using methylene blue dye and who observed (after killing and frontal brain sectioning) that the injection was successful in more than 95% of the trials. The i.c.v. injection method was approved by the Regional Ethical Committee for Animal Experimentation (Normandy; no. N/10-04-04-12).
Food Consumption Experiments in Food-Deprived Mice or Food-Restricted Mice
Two days before the experiments, mice were isolated in individual cages (L: 24 cm, W: 10, and H: 7 cm) with free access to water and the pellets of food laid down the floor of the cages, in order to make the animals accustomed to the test conditions. For experiments with food-deprived mice (fasted mice) (in order to evaluate an anorexigenic effect), 18 h before testing (1500-0900 h), animals were totally deprived of food and had access to tap water ad libitum. For experiments with food-restricted mice (in order to evaluate an orexigenic effect), 18 h before testing (1500-0900 h), animals had access to only 3 g of food (that represented approximately half of their daily consumption) and water ad libitum. In all groups, mice had access to a weighed food pellet (5 g) deposited on the floor of the cage 10 min after i.c.v. administration of saline, peptides, and/or drugs. Thereafter, the pellet was briefly (o20 s) removed with forceps and weighed every 30 min, for 3 h. The food consumption method was approved by the Regional Ethical Committee for Animal Experimentation (Normandy; no. N/13-04-04-15).
Measurement of Locomotor Activity
Ten min after i.c.v. administration of saline or peptides, the animals were placed individually in 20 Â 20 Â 30 cm compartments, in a lighted and quiet room. Locomotor activity was assessed automatically in a Digiscan actimeter (Omnitech Electronics Inc, Colombus, OH), which monitored the horizontal displacements and vertical movements, including rearing, leaning, and jumping. The responses were expressed as the total number of beams crossed by mice during four consecutive 15-min periods.
Statistical Analysis
Data are expressed as means7SEM. Differences between groups were assessed by one-way analysis of variance (ANOVA) followed by a post hoc multiple comparison Student-Newman-Keuls test. Antagonistic effects were analyzed using two-way ANOVA, and a post hoc multiple comparison Student-Newman-Keuls test was used for multiple comparisons between groups. A probability level of 0.05 or lower was considered as statistically significant.
RESULTS
Effects of ODN, OP, and cOP on Food Intake in Food-Deprived Mice
In food-deprived mice, i.c.v. injection of 100 ng ODN, OP, or cOP significantly reduced (po0.001) food intake during the first 30-min period of testing. The mean7SEM percentage of food intake inhibition induced by these peptides is: 55.376.8% for ODN, 68.978.1% for OP, and 51.577.4% for cOP. Thereafter, the anorexigenic effect of all three peptides gradually vanished but the cumulative food consumption remained significantly reduced during the whole 3-h test period (Figure 1 ).
Effects of ODN, OP, and cOP on Locomotor Activity
The influence of i. Cumulative food intake (mg)
Time after food presentation (min) * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Figure 1 Time course of the effect of ODN, OP, or cOP on food intake in food-deprived mice. Mice deprived of food for 18 h were injected i.c.v. (10 ml) with saline, ODN (100 ng/mouse), OP (100 ng/mouse), or cOP(100 ng/mouse). Ten min after i.c.v. injection, each animal had access to a weighed food pellet. Cumulative food intake was measured during 3 h at the time indicated. Mean7SEM represents data from 14 mice per group. Student-Newman-Keuls post hoc test: *po0.05, **po0.01, ***po0.001 vs saline-injected mice. ]OP (cDLOP; a, 100 ng/ mouse; b, 500 ng/mouse; c, 1000 ng/mouse). Ten min after i.c.v. injection, each animal had access to a weighed food pellet. Cumulative food intake was measured during 3 h at the time indicated. Mean7SEM represents data from 10 to 24 mice per group. Student-Newman-Keuls test: *po0.05, **po0.01, ***po0.001 vs saline-injected mice. A two-way ANOVA revealed a significant interaction: between cDLOP (500 ng/ mouse) and ODN at 30 min F (1,36) ]OP (cDLOP; a, 100 ng/ mouse; b, 500 ng/mouse; c, 1000 ng/mouse). Ten min after i.c.v. injection, each animal had access to a weighed food pellet. Cumulative food intake was measured during 3 h at the time indicated. Mean7SEM represents data from 10 to 24 mice per group. Student-Newman-Keuls test: *po0.05, **po0.01, ***po0.001 vs saline injected-mice. A two-way ANOVA revealed a significant interaction between cDLOP (500 ng/mouse) and OP at 30 min F (1,44) before i.c.v. administration of ODN, had no effect on ODN-induced inhibition of food intake during the 3-h test period (Figure 3a) . The inhibitory effect of ODN was not affected either by i.c.v. co-administration of flumazenil or PK11195 (Figure 3b) . At the lowest dose tested (100 ng/mouse, i.c.v.), cDLOP did not impair the anorexigenic effect of ODN (Figure 4a 
Effect of cDLOP on Food Intake in Food-Restricted Mice
In mice that received approximately half of their daily consumption of food for 18 h (1500-0900), i.c.v. administration of graded doses of cDLOP (100-2000 ng/ mouse) provoked a dose-related increase of cumulative food intake reaching statistical significance at a dose of 500 ng/mouse (Figure 7 ). For doses ranging from 500 to 2000 ng/mouse, cDLOP induced a significant orexigenic effect during the whole duration of the test with an increase in cumulative food consumption of 98.1713.8% for the 500 ng dose, 155.1725.6% for the 1000 ng, and 209.2714.6 for the 2000 ng dose, at the end of the 3-h test period (Figure 7) .
Effects of Flumazenil, PK11195, and ODN on cDLOP-Induced Orexigenic Effect in Food-Restricted Mice I.c.v. administration of flumazenil (2 mg/mouse) or PK11195 (2 mg/mouse) in food-restricted mice had no effect on food ]OP (cDLOP; a, 100 ng/mouse; b, 500 ng/mouse; c, 1000 ng/mouse). Ten min after i.c.v. injection, each animal had access to a weighed food pellet. Cumulative food intake was determined during 3 h at the time indicated. Mean7SEM represents data from 10 to 24 mice per group. Student-Newman-Keuls test *po0.05, **po0.01, ***po0.001 vs saline-injected mice. A two-way ANOVA revealed a significant interaction: between cDLOP (500 ng/mouse) and cOP at 30 min F(1,44) ¼ 19.5, consumption and did not significantly alter the orexigenic effect of cDLOP (500 ng/mouse), during the whole 3-h test period (Figure 8) . In contrast, i.c.v. co-administration of ODN (10, 100, 200, or 300 ng/mouse) with cDLOP (500 ng/ mouse) reversed the orexigenic effect of cDLOP and dose dependently restored its own anorexigenic effect (Figure 9 ). When injected alone, increasing doses of ODN (100, 200, and 300 ng/mouse) dose dependently and significantly decreased (po0.05-0.001) the cumulative food intake in food-restricted mice (Figure 9 ).
DISCUSSION
It has previously been reported that very low doses of ODN inhibit food intake in rat and mice (Garcia de MateosVerchere et al, 2001 ) but the pharmacological profile of the receptor involved in the effect of ODN had not been characterized. In the present study, we show that the anorexigenic action of ODN is mimicked by the C-terminal fragment of ODN (OP) and its head-to-tail cyclic analog (cOP). Indeed, the C-terminal domain of ODN is capable of inducing several of the effects of ODN such as the anxiogenic activity (Garcia de Mateos-Verchere et al, 1998a) , the inhibition of apomorphine-induced yawning (Garcia de Mateos-Verchere et al, 1998b) and the inhibition of pentylenetetrazol-induced convulsions (Garcia de Mateos-Verchere et al, 1999) . Interestingly, in the present study, we did not observe any effect of ODN, OP, or cOP on motor activity, indicating that the inhibitory effect of ODN and related peptides on food consumption could not be ascribed to a sedation or psychostimulant activity of these compounds.
It is now clearly established that ODN can interact with CBR associated with the GABA A receptor (Ferrero et al, 1986; Tonon et al, 1989; Slobodyansky et al, 1990) . In addition, it has been shown that several of the effects induced by ODN are mediated via a G-proteincoupled receptor. In particular, in vitro studies have shown that ODN increases intracellular calcium concentration in cultured rat astrocytes through activation of a metabotropic receptor positively coupled to phospholipase C (Patte et al, 1995; Gandolfo et al, 1997) . We have previously observed that the inhibitory effect of ODN on feeding behavior is not affected by diazepam, a mixed CBR and PBR agonist (Garcia de Mateos-Verchere et al, 2001) . In order to further characterize the type of receptor mediating the anorexigenic action of ODN and its analogs, in the present study we have investigated the effect of selective endozepine receptor antagonists on ODN, OP, and cOP-induced food consumption. The specific CBR antagonist flumazenil (Bonetti et al, 1982) and the specific PBR antagonist PK11195 (Le Fur et al, 1983) did not prevent the inhibitory effect of ODN, OP, and cOP on food intake. Conversely, cDLOP, which acts as a metabotropic endozepine receptor antagonist , suppressed the anorexigenic effect of ODN, OP, and cOP. These data indicate that the effects of ODN and its analogs on feeding behavior are mediated through activation of the recently characterized metabotropic receptor. Moreover, at the highest dose tested (1000 ng/mouse), cDLOP not only suppressed the inhibitory effect of ODN on food intake, but significantly increased by its own food consumption, indicating that endogenous ligands of the metabotropic endozepine receptor, including ODN, exert a tonic inhibitory effect on feeding behavior. Of note, cDLOP has already been used successfully to decipher physiological actions of endozepines in the brain. Thus, it has been recently shown that cDLOP not only prevented the inhibitory effects of ODN on gonadotropin-releasing hormone (GnRH) and NPY gene expression but also increased by itself GnRH and NPY mRNA levels (Compère et al, 2004 (Compère et al, , 2005 . Consistent with an endozepinergic tonus controlling feeding, in the present study, we found that the stimulatory action of cDLOP on food consumption was completely abolished by ODN. These data indicate that the orexigenic effect of cDLOP and the anorexigenic effect of ODN are mediated through activation of the same receptor. This latter observation provides strong evidence for the involvement of endozepine metabotropic receptors in the control of feeding.
In conclusion, the present study provides direct evidence that, in mice, the anorexigenic effect of ODN involves receptors that are distinct from the classical CBR and PBR. The pharmacological profile of these receptors corresponds to that of the metabotropic endozepine receptor positively coupled to phospholipase C. Our results also suggest the existence of an endozepinergic tonus that appears to play an important role in the regulation of feeding behavior. 
